Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2014-02-19 Director's Dealing
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2014-02-19 English
SURMODICS, INC. 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 17, 2014, by SurModics, Inc. The key content includes the resignation of a board member and the appointment of two new directors, along with details about their compensation and changes to the board compensation policy. The document focuses on changes in the company's board of directors and related governance matters. There is no financial data or earnings information presented, nor is it a report or announcement of a report publication. The primary subject is clearly the change in board membership and related compensation policy amendments, which fits the category of Board/Management Information (MANG).
2014-02-18 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-02-12 English
4 Filing
Director's Dealing
2014-02-12 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 4, 2014, reporting the submission of matters to a vote of security holders at the company's 2014 Annual Meeting of Shareholders. It details the final voting results on director elections, number of directors, auditor ratification, and advisory vote on executive compensation. This matches the description of a Declaration of Voting Results & Voting Rights Announcements, which reports official results from shareholder votes at general meetings. The document is not a full report or presentation but a formal announcement of voting outcomes.
2014-02-10 English
FORM 4 SUBMISSION
Director's Dealing
2014-02-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.